Balance Sheet Vineet Laboratories Limited

Stocks

VINEETLAB

INE505Y01010

Pharmaceuticals

Market Closed - NSE India S.E. 04:35:11 21/08/2026 pm IST			5-day change	1st Jan Change
37.81 ^INR	-1.77%		-1.64%	+2.80%

21/07	Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026	CI
29/05	Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026	CI

2f6193eaf3f9fd.7QjrsSnbJmTaIyPzozjHk6Y9XKlill-noTH6byXB81I.iTCo5U60Hj2fZkW-lWrz1YtoDO4E9BTR9WOtVmCHlB-5WZreH5YUKuNSYg

Published financial data: VINEET LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	243.48Cr	191.17Cr	212.29Cr	150.59Cr	75Cr
Other Revenues, Total	-	-	-	37.29L	1.96Cr
Total Revenues	243.48Cr	191.17Cr	212.29Cr	150.96Cr	77Cr
Cost of Goods Sold, Total	200.03Cr	149.75Cr	176.1Cr	118.06Cr	73Cr
Gross Profit	43Cr	41Cr	36Cr	33Cr	3.88Cr
Selling General & Admin Expenses, Total	5.64Cr	5.03Cr	6.07Cr	6.48Cr	5.38Cr
Depreciation & Amortization - (IS)	1.81Cr	2.02Cr	2.37Cr	2.52Cr	2.5Cr
Other Operating Expenses	30Cr	23Cr	22Cr	19Cr	13Cr
Other Operating Expenses, Total	37Cr	30Cr	31Cr	28Cr	21Cr
Operating Income	6.35Cr	11Cr	5.62Cr	5.05Cr	-17Cr
Interest Expense, Total	-2.67Cr	-2.17Cr	-2.66Cr	-3.85Cr	-3.83Cr
Interest And Investment Income	5L	16.24L	12.3L	4L	-
Net Interest Expenses	-2.62Cr	-2.01Cr	-2.54Cr	-3.81Cr	-3.83Cr
Currency Exchange Gains (Loss)	27.44L	9L	-33.72L	68T	42T
Other Non Operating Income (Expenses)	5L	3L	-72.18L	-93.19L	-14.69L
EBT, Excl. Unusual Items	4.06Cr	9.35Cr	2.03Cr	31.53L	-21Cr
Gain (Loss) On Sale Of Investments	-	-	-	5L	2L
EBT, Incl. Unusual Items	4.06Cr	9.35Cr	2.03Cr	36.34L	-21Cr
Income Tax Expense	2.28Cr	2.71Cr	77.74L	-66.37L	-58.45L
Earnings From Continuing Operations	1.78Cr	6.64Cr	1.25Cr	1.03Cr	-20Cr
Net Income to Company	1.78Cr	6.64Cr	1.25Cr	1.03Cr	-20Cr
Net Income - (IS)	1.78Cr	6.64Cr	1.25Cr	1.03Cr	-20Cr
Net Income to Common Incl Extra Items	1.78Cr	6.64Cr	1.25Cr	1.03Cr	-20Cr
Net Income to Common Excl. Extra Items	1.78Cr	6.64Cr	1.25Cr	1.03Cr	-20Cr
Per Share Items
Net EPS - Basic	1.93	7.2	1.36	1.11	-21.9
Basic EPS - Continuing Operations	1.93	7.2	1.36	1.11	-21.9
Basic Weighted Average Shares Outstanding	92.19L	92.19L	92.19L	92.19L	92.19L
Net EPS - Diluted	1.93	7.2	1.36	1.11	-21.9
Diluted EPS - Continuing Operations	1.93	7.2	1.36	1.11	-21.9
Diluted Weighted Average Shares Outstanding	92.19L	92.19L	92.19L	92.19L	92.19L
Normalized Basic EPS	2.75	6.34	1.38	0.21	-14.1
Normalized Diluted EPS	2.75	6.34	1.38	0.21	-14.1
Dividend Per Share	-	1	-	-	-
Payout Ratio	-	-	73.6	-	-
Supplemental Items
EBITDA	8.16Cr	13Cr	8Cr	7.43Cr	-14Cr
EBITA	6.35Cr	11Cr	5.62Cr	5.05Cr	-17Cr
EBIT	6.35Cr	11Cr	5.62Cr	5.05Cr	-17Cr
EBITDAR	8.19Cr	13Cr	8.02Cr	7.47Cr	-14Cr
Total Revenues (As Reported)	243.86Cr	191.46Cr	212.42Cr	151.05Cr	77Cr
Effective Tax Rate - (Ratio)	56.13	28.97	38.3	-182.64	2.81
Total Current Taxes	1.28Cr	3.18Cr	56.02L	-6L	-
Total Deferred Taxes	99.93L	-47.63L	21.72L	-59.89L	-58.45L
Normalized Net Income	2.54Cr	5.84Cr	1.27Cr	19.71L	-13Cr
Interest on Long-Term Debt	2.03Cr	22.37L	33.85L	71.14L	48.28L
Non-Cash Pension Expense	-	5L	-9T	6L	7L
Supplemental Operating Expense Items
Advertising Expense	3L	8L	5L	6L	49T
Selling and Marketing Expenses	3L	8L	5L	6L	49T
Net Rental Expense, Total	3L	5L	2L	4L	3L
Imputed Operating Lease Interest Expense	-	4L	1L	3L	3L
Imputed Operating Lease Depreciation	-	50.42T	47.61T	72.13T	94.3T
Maintenance & Repair Expenses, Total	1.91Cr	4.2Cr	3.77Cr	4.14Cr	2.84Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.1Cr	18Cr	63.07L	22.78L	30.68L
Total Cash And Short Term Investments	2.1Cr	18Cr	63.07L	22.78L	30.68L
Accounts Receivable, Total	43Cr	36Cr	35Cr	32Cr	13Cr
Other Receivables	-	-	3L	6L	-
Total Receivables	43Cr	36Cr	35Cr	32Cr	13Cr
Inventory	40Cr	44Cr	46Cr	49Cr	50Cr
Other Current Assets, Total	1.86Cr	4.87Cr	5.47Cr	6.9Cr	3.87Cr
Total Current Assets	86Cr	102.73Cr	87Cr	88Cr	67Cr
Gross Property Plant And Equipment	35Cr	39Cr	47Cr	50Cr	51Cr
Accumulated Depreciation	-16Cr	-18Cr	-20Cr	-23Cr	-25Cr
Net Property Plant And Equipment	20Cr	21Cr	27Cr	27Cr	25Cr
Long-term Investments	11.8L	13.57L	13.35L	18.16L	20.63L
Accounts Receivable Long-Term	1.33Cr	4.03Cr	-	-	-
Other Long-Term Assets, Total	1.26Cr	5.35Cr	1.61Cr	1.59Cr	1.48Cr
Total Assets	108.74Cr	133.63Cr	115.85Cr	116.87Cr	95Cr
Liabilities
Accounts Payable, Total	56Cr	60Cr	35Cr	32Cr	34Cr
Accrued Expenses, Total	2.33Cr	2.02Cr	2.37Cr	3.01Cr	3.51Cr
Short-term Borrowings	9.01Cr	25Cr	25Cr	39Cr	35Cr
Current Portion of Long-Term Debt	-	-	1.04Cr	1.32Cr	98.58L
Current Income Taxes Payable	1.24Cr	3.18Cr	43.99L	12.23L	-
Unearned Revenue Current, Total	15.03L	-	-	-	-
Other Current Liabilities	5.94Cr	5Cr	11Cr	19.55L	1.01Cr
Total Current Liabilities	75Cr	95Cr	75Cr	76Cr	74Cr
Long-Term Debt	3.47Cr	1.72Cr	4.85Cr	3.89Cr	3.79Cr
Pension & Other Post Retirement Benefits	84.69L	87.43L	58.78L	63.05L	64.22L
Deferred Tax Liability Non Current	2.27Cr	1.79Cr	2.05Cr	1.46Cr	91.34L
Other Non Current Liabilities	89.68L	94.19L	16.66L	17.58L	16.21L
Total Liabilities	82Cr	100.41Cr	82Cr	82Cr	80Cr
Common Stock, Total	9.22Cr	9.22Cr	9.22Cr	9.22Cr	9.22Cr
Retained Earnings	6.31Cr	13Cr	13Cr	14Cr	-5.92Cr
Comprehensive Income and Other	11Cr	11Cr	11Cr	11Cr	11Cr
Total Common Equity	27Cr	33Cr	34Cr	35Cr	15Cr
Total Equity	27Cr	33Cr	34Cr	35Cr	15Cr
Total Liabilities And Equity	108.74Cr	133.63Cr	115.85Cr	116.87Cr	95Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	92.19L	92.19L	92.19L	92.19L	92.19L
ECS Total Common Shares Outstanding	92.19L	92.19L	92.19L	92.19L	92.19L
Book Value / Share	28.87	36.03	36.54	37.67	15.89
Tangible Book Value	27Cr	33Cr	34Cr	35Cr	15Cr
Tangible Book Value Per Share	28.87	36.03	36.54	37.67	15.89
Total Debt	12Cr	27Cr	31Cr	44Cr	40Cr
Net Debt	10Cr	8.4Cr	30Cr	44Cr	40Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	98.42L	98.47L
Debt Equivalent Oper. Leases	27.52L	36.64L	14.56L	31.52L	27.6L
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	40Cr	24Cr	31Cr	16Cr	23Cr
Inventories - Work In Process, Total	-	20Cr	15Cr	33Cr	27Cr
Land - (BS)	12.25L	12.25L	12.25L	12.25L	12.25L
Buildings, Total	4.33Cr	4.33Cr	-	4.77Cr	4.77Cr
Machinery, Total	31Cr	35Cr	42Cr	45Cr	46Cr
Full Time Employees	87	66	72	79	57

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	1.78Cr	6.64Cr	1.25Cr	1.03Cr	-20Cr
Depreciation & Amortization - CF	1.81Cr	2.02Cr	2.37Cr	-4L	2.5Cr
Depreciation & Amortization, Total	1.81Cr	2.02Cr	2.37Cr	-4L	2.5Cr
(Gain) Loss on Sale of Investments - (CF)	-	-	22T	-5L	-2L
Other Operating Activities, Total	7.03Cr	1.49Cr	1.56Cr	1.13Cr	5.25Cr
Change In Accounts Receivable	-43Cr	6.52Cr	5.07Cr	3.56Cr	18Cr
Change In Inventories	-40Cr	-3.85Cr	-2.63Cr	-3.22Cr	-57.69L
Change In Accounts Payable	56Cr	4.1Cr	-26Cr	-2.63Cr	1.36Cr
Change in Other Net Operating Assets	7.08Cr	-9.2Cr	9.01Cr	-11Cr	4.81Cr
Cash from Operations	-8.71Cr	7.71Cr	-9.62Cr	-11Cr	11Cr
Capital Expenditure	-	-	-7.63Cr	-23.43L	-1.05Cr
Investment in Marketable and Equity Securities, Total	-7.85Cr	-3.73Cr	82.56L	-	-
Other Investing Activities, Total	5L	16.24L	12.3L	56.69L	-2.14Cr
Cash from Investing	-7.81Cr	-3.57Cr	-6.69Cr	33.26L	-3.18Cr
Short Term Debt Issued, Total	-	-	40.61L	14Cr	-
Long-Term Debt Issued, Total	12Cr	14Cr	4.17Cr	5.19Cr	20L
Total Debt Issued	12Cr	14Cr	4.58Cr	19Cr	20L
Short Term Debt Repaid, Total	-	-	-	-	-3.82Cr
Long-Term Debt Repaid, Total	-	-	-	-5.87Cr	-63.39L
Total Debt Repaid	-	-	-	-5.87Cr	-4.45Cr
Issuance of Common Stock	8.81Cr	-	-	-	-
Common Dividends Paid	-	-	-92.19L	-	-
Common & Preferred Stock Dividends Paid	-	-	-92.19L	-	-
Other Financing Activities, Total	-2.67Cr	-2.17Cr	-3.38Cr	-2.52Cr	-3.98Cr
Cash from Financing	19Cr	12Cr	27.31L	11Cr	-8.23Cr
Miscellaneous Cash Flow Adjustments	-	-1T	1T	-	1T
Net Change in Cash	2.1Cr	16Cr	-16Cr	-40.29L	8L
Supplemental Items
Cash Interest Paid	2.67Cr	2.17Cr	3.38Cr	2.52Cr	3.98Cr
Cash Income Tax Paid (Refund)	-85.16L	-	2.99Cr	25.28L	12.23L
Levered Free Cash Flow	-14Cr	12Cr	-26Cr	-13Cr	12Cr
Unlevered Free Cash Flow	-12Cr	13Cr	-24Cr	-11Cr	14Cr
Change In Net Working Capital	18Cr	-4.3Cr	22Cr	14Cr	-23Cr
Net Debt Issued / Repaid	12Cr	14Cr	4.58Cr	13Cr	-4.25Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.27	5.79	2.82	2.71	-9.95
Return on Total Capital	20.1	14.2	5.65	4.39	-15.73
Return On Equity %	13.18	22.19	3.74	3	-81.79
Return on Common Equity	13.18	22.19	3.74	3	-81.79
Margin Analysis
Gross Profit Margin %	17.85	21.67	17.05	21.8	5.04
SG&A Margin	2.32	2.63	2.86	4.29	6.98
EBITDA Margin %	3.35	6.93	3.77	4.92	-18.62
EBITA Margin %	2.61	5.87	2.65	3.35	-21.87
EBIT Margin %	2.61	5.87	2.65	3.35	-21.87
Income From Continuing Operations Margin %	0.73	3.47	0.59	0.68	-26.24
Net Income Margin %	0.73	3.47	0.59	0.68	-26.24
Net Avail. For Common Margin %	0.73	3.47	0.59	0.68	-26.24
Normalized Net Income Margin	1.04	3.06	0.6	0.13	-16.89
Levered Free Cash Flow Margin	-5.8	6.26	-12.2	-8.83	15.55
Unlevered Free Cash Flow Margin	-5.11	6.97	-11.42	-7.24	18.66
Asset Turnover
Asset Turnover	4.46	1.58	1.7	1.3	0.73
Fixed Assets Turnover	-	9.31	8.84	5.64	2.94
Receivables Turnover (Average Receivables)	-	4.85	5.95	4.51	3.34
Inventory Turnover (Average Inventory)	-	3.6	3.93	2.47	1.47
Short Term Liquidity
Current Ratio	1.16	1.08	1.17	1.16	0.91
Quick Ratio	0.6	0.57	0.48	0.42	0.18
Operating Cash Flow to Current Liabilities	-0.12	0.08	-0.13	-0.15	0.15
Days Sales Outstanding (Average Receivables)	-	75.33	61.35	81.14	109.14
Days Outstanding Inventory (Average Inventory)	-	101.43	92.97	148.14	248.15
Average Days Payable Outstanding	-	137.92	96.99	101.33	163.21
Cash Conversion Cycle (Average Days)	-	38.84	57.33	127.95	194.08
Long Term Solvency
Total Debt/Equity	46.86	79.82	92.3	127.58	273.4
Total Debt / Total Capital	31.91	44.39	48	56.06	73.22
LT Debt/Equity	13.02	5.18	14.39	11.19	25.85
Long-Term Debt / Total Capital	8.87	2.88	7.48	4.92	6.92
Total Liabilities / Total Assets	75.52	75.14	70.92	70.29	84.51
EBIT / Interest Expense	2.38	5.18	2.12	1.31	-4.39
EBITDA / Interest Expense	3.06	6.11	3.01	1.93	-3.74
(EBITDA - Capex) / Interest Expense	3.06	6.11	0.14	1.87	-4.01
Total Debt / EBITDA	1.53	2	3.89	5.96	-2.8
Net Debt / EBITDA	1.27	0.63	3.81	5.93	-2.77
Total Debt / (EBITDA - Capex)	1.53	2	85.71	6.16	-2.61
Net Debt / (EBITDA - Capex)	1.27	0.63	83.98	6.13	-2.59
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-21.48	11.05	-28.89	-49.03
Gross Profit, 1 Yr. Growth %	-20.94L	-4.67	-12.63	-9.08	-88.22
EBITDA, 1 Yr. Growth %	-	62.37	-39.24	1.42	-289.16
EBITA, 1 Yr. Growth %	-57.3T	76.83	-49.54	2.11	-432.93
EBIT, 1 Yr. Growth %	-57.3T	76.83	-49.54	2.11	-432.93
Earnings From Cont. Operations, 1 Yr. Growth %	-16.14T	272.89	-81.13	-18	-2.07T
Net Income, 1 Yr. Growth %	-16.14T	272.89	-81.13	-18	-2.07T
Normalized Net Income, 1 Yr. Growth %	-36.65T	130.28	-78.28	-84.47	-6.7T
Diluted EPS Before Extra, 1 Yr. Growth %	-813.16	272.89	-81.13	-18.3	-2.07T
Accounts Receivable, 1 Yr. Growth %	-	-15.25	-2.86	-10.12	-58.08
Inventory, 1 Yr. Growth %	-	9.71	6.05	6.97	1.17
Net Property, Plant and Equip., 1 Yr. Growth %	-	8.74	24.61	1.01	-5.41
Total Assets, 1 Yr. Growth %	27.13T	22.89	-13.1	0.88	-19.11
Tangible Book Value, 1 Yr. Growth %	6.57T	24.81	1.4	3.09	-57.82
Common Equity, 1 Yr. Growth %	6.57T	24.81	1.4	3.09	-57.82
Cash From Operations, 1 Yr. Growth %	3L	-71.93	-226	18.83	-273.82
Capital Expenditures, 1 Yr. Growth %	-	-	-	-96.93	-62.52
Levered Free Cash Flow, 1 Yr. Growth %	-	-184.85	-344.34	-49.36	-189.75
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-207.1	-310.21	-55.7	-231.42
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-6.62	-11.14	-39.79
Gross Profit, 2 Yr. CAGR %	-	14.03T	-8.74	-10.87	-67.27
EBITDA, 2 Yr. CAGR %	-	-	-0.99	-24.88	39.87
EBITA, 2 Yr. CAGR %	-	3.08T	-5.89	-32.66	84.38
EBIT, 2 Yr. CAGR %	-	3.08T	-5.89	-32.66	84.38
Earnings From Cont. Operations, 2 Yr. CAGR %	-	2.35T	-16.12	-60.67	301.5
Net Income, 2 Yr. CAGR %	-	2.35T	-16.12	-60.67	301.5
Normalized Net Income, 2 Yr. CAGR %	-	2.8T	-29.28	-81.63	220.11
Diluted EPS Before Extra, 2 Yr. CAGR %	-	415.69	-16.12	-60.74	301.5
Accounts Receivable, 2 Yr. CAGR %	-	-	-9.27	-6.56	-38.62
Inventory, 2 Yr. CAGR %	-	-	7.87	6.51	4.03
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	16.4	12.19	-2.25
Total Assets, 2 Yr. CAGR %	-	1.73T	3.22	-6.37	-9.66
Tangible Book Value, 2 Yr. CAGR %	-	812.55	12.5	2.24	-34.06
Common Equity, 2 Yr. CAGR %	-	812.55	12.5	2.24	-34.06
Cash From Operations, 2 Yr. CAGR %	-	4.92T	-40.85	22.36	9.31
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-63
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	35.47	12.14	-32.59
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	39.56	-2.67	-23.7
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-14.73	-26.16
Gross Profit, 3 Yr. CAGR %	-	-	2.49T	-8.85	-54.6
EBITDA, 3 Yr. CAGR %	-	-	-	-3.08	2.86
EBITA, 3 Yr. CAGR %	-	-	697.18	-7.33	14.72
EBIT, 3 Yr. CAGR %	-	-	697.18	-7.33	14.72
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	383.2	-16.75	44.89
Net Income, 3 Yr. CAGR %	-	-	383.2	-16.75	44.89
Normalized Net Income, 3 Yr. CAGR %	-	-	467.58	-57.33	30.56
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	71.2	-16.85	44.89
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-9.55	-28.47
Inventory, 3 Yr. CAGR %	-	-	-	7.57	4.7
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	11.03	5.99
Total Assets, 3 Yr. CAGR %	-	-	562.01	2.43	-10.82
Tangible Book Value, 3 Yr. CAGR %	-	-	338.72	9.27	-23.89
Common Equity, 3 Yr. CAGR %	-	-	338.72	9.27	-23.89
Cash From Operations, 3 Yr. CAGR %	-	-	1.36T	-25.36	14.61
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-1.88	4.11
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-4.25	7.58
Compound Annual Growth Rate Over Five Years
Gross Profit, 5 Yr. CAGR %	-	-	-	-	351.1
EBITA, 5 Yr. CAGR %	-	-	-	-	332.63
EBIT, 5 Yr. CAGR %	-	-	-	-	332.63
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	348.7
Net Income, 5 Yr. CAGR %	-	-	-	-	348.7
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	351.37
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	140.75
Total Assets, 5 Yr. CAGR %	-	-	-	-	198.44
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	105.58
Common Equity, 5 Yr. CAGR %	-	-	-	-	105.58
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	418.55